Repurposing SKQ1 as a meropenem potentiator against NDM-1-producing <i>Escherichia coli</i>. [PDF]
Li X +9 more
europepmc +1 more source
Outcome of Ceftazidime/Avibactam Versus Alternative Antibiotics for Treatment of Carbapenem-Resistant <i>Enterobacterales</i> Bacteremia in Patients With Hematologic Malignancies. [PDF]
Jang HM +9 more
europepmc +1 more source
Population pharmacokinetic model for meropenem in pediatric patients: a systematic review. [PDF]
Gao H +5 more
europepmc +1 more source
Stability Study of Meropenem 50 mg/mL Eye Drops in Polypropylene Dropper Bottles. [PDF]
Ramirez JCR +5 more
europepmc +1 more source
Comparison of Ceftolozane-Tazobactam Versus Meropenem Regimens in Treating Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing <i>Enterobacterales</i>: Real-World Data from a Greek Tertiary Center. [PDF]
Petrakis V +11 more
europepmc +1 more source
Pharmacokinetics, safety and population pharmacokinetics/pharmacodynamics analysis of meropenem-vaborbactam in Chinese healthy participants. [PDF]
Li W +15 more
europepmc +1 more source
Antimicrobial Resistance Patterns Among Gram-Negative Bacterial Isolates Recovered from Tracheal Aspirate Cultures in Türkiye: A Systematic Review and Meta-Analysis. [PDF]
Kahraman Kilbas EP +3 more
europepmc +1 more source
Quantifying antibiotic susceptibility and inoculum effects using transient dynamics of Pseudomonas aeruginosa. [PDF]
Sundius S +4 more
europepmc +1 more source
Meropenem Use and Challenges in Treating Severe Infections in Pakistan Amid Antimicrobial Resistance. [PDF]
Akhtar N +6 more
europepmc +1 more source
Distribution of Non-Fermenting Gram-Negative Bacilli and Carbapenem Resistance Profiles in Intensive Care Units of a Foundation University Hospital: A 2023-2025 Retrospective Analysis. [PDF]
Ozturk Akin H, Unlu O.
europepmc +1 more source

